Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane
- 9 October 2001
- journal article
- research article
- Published by Wiley in Microscopy Research and Technique
- Vol. 55 (2) , 100-107
Abstract
It has generally been assumed that tumors do not induce lymphangiogenesis and only very recently animal models have been presented showing tumor‐induced lymphangiogenesis. We have grown two types of rat tumor cells, 10AS pancreatic carcinoma and C6 glioma cells, on the chorioallantoic membrane (CAM) of chick and quail embryos. The suspended tumor cells rapidly formed solid tumors which invaded the CAM and were vascularized by CAM vessels. When grown on the CAM of quail embryos intratumoral endothelial cells could be specifically stained with the QH1 antibody. In C6 gliomas the vascular pattern was more regular than in 10AS carcinomas. The vessels often grew radially into the glioma and many of them were invested by smooth muscle α‐actin‐positive periendothelial cells. Lymphatics, which were identified by vascular endothelial growth factor receptor‐3 (VEGFR‐3) in situ hybridization were absent from C6 gliomas, although a weak expression of the lymphangiogenic growth factor, VEGF‐C, could be detected in the C6 cells by Northern blot analysis. In contrast, 10AS cells, which expressed high levels of VEGF‐C, induced ingrowth of lymphatics into the tumors, with BrdU‐labeling rates of about 9% of lymphatic endothelial cells. Our studies demonstrate the heterogeneity of interactions of tumor cells with blood vessels and lymphatics and show that sufficient quantities and/or quality of lymphangiogenic growth factors are crucial for the induction of lymphatics in tumors. Microsc. Res. Tech. 55:100–107, 2001.Keywords
This publication has 40 references indexed in Scilit:
- Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological FeaturesThe American Journal of Pathology, 1999
- Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular developmentGenes & Development, 1999
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- Proteolytic processing regulates receptor specificity and activity of VEGF‐CThe EMBO Journal, 1997
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- Molecular cloning of Quek 1 and 2, two quail vascular endothelial growth factor (VEGF) receptor-like moleculesGene, 1996
- Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interlenkin-2Journal of Neuro-Oncology, 1996
- Role of lymphagenesis in neovascularisationThe Lancet, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- The Cultivation of Tumours in the Fertile Egg, with Special Reference to Associated Ectodermal Lesions of the Chorioallantoic MembraneBritish Journal of Cancer, 1949